. 2022 Jul 28;50(7):03000605221110067. doi: 10.1177/03000605221110067

Table 2.

Clinical characteristics and laboratory results of patients with moderate and severe COVID-19.

Variable	Moderate COVID-19 group	Severe COVID-19 group	Reference value	P-value
Age (years, mean ± SD)	61.86 ± 17.4	60.8 ± 19.18		0.8
≥60	27	10		0.5
<60	30	10		0.5
Sex (%)				0.3
Male	27	8
Female	30	12
AST (mean ± SD, IU/L)	141.98 ± 668.42	132.5 ± 261.8	5–40	0.9
	55	20		0.9
ALT (mean ± SD, IU/L)	76.1 ± 289.1	82.16 ± 146.98	5–40	0.9
	56	19		0.9
ALP (mean ± SD, IU/L)	220.2 ± 187.1	246 ± 165.34	64–306	0.5
	53	19		0.5
LDH (mean ± SD, U/mL)	866.65 ± 493.93	1036.2 ± 770		0.5
	23	6		0.5
RBC (mean ± SD, million/mm³)	5.43 ± 4.37	4.72 ± 0.71	Male: 4.5–6.3Female: 4.2–5.4	0.4
	55	19		0.4
WBC (mean ± SD, /mm³)	9.58 ± 5	8.85 ± 5.15	4000–10000	0.5
	55	19		0.5
HCT (mean ± SD, %)	41.11 ± 4.28	40.88 ± 4.57	Male: 39–52Female: 36–46	0.8
	55	19		0.8
NLR (mean ± SD)	8.71 ± 6.73	9.25 ± 5.94	1.70 ± 0.07	0.7
	55	19		0.7
PLR (mean ± SD)	250.33 ± 130.67	229.9 ± 139.96	117.05 ± 47.73	0.5
	55	19		0.5
LMR (mean ± SD)	3.15 ± 1.98	5.11 ± 7.35	11.15 ± 3.14	0.07
	55	19		0.07
CRP	3.02 ± 1.1	2.64 ± 1.39	1–4	0.3
	44	14		0.3
Pt (mean ± SD, /mm³)	12.79 ± 2.22	12.71 ± 0.83	12.5	0.7
	50	14		0.7
PTT (s)	38.29 ± 28.52	37.33 ± 7.2	24–35	0.8
	49	14		0.8
D-dimer	positive 2 (18.2%); negative 2 (25%)	positive 9 (81.8%); negative 6 (75%)		0.574
	15	4		0.574
ESR	38.1 ± 15.92	36.25 ± 19.71	Male: <15 mm/h; Female: <20 mm/h	0.7
	30	8		0.7

ALP: alkaline phosphatase; LDH: lactate dehydrogenase; RBC: red blood cell; WBC: white blood cell; HCT: hematocrit; NLR: neutrophil/lymphocyte ratio; PLR: platelet/lymphocyte/ratio; LMR: lymphocyte/monocyte ratio; CRP: C-reactive protein; Pt: platelet; PTT: partial thromboplastin time; ESR: erythrocyte sedimentation rate.